Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101

Critical limb ischemia (CLI) has a poor prognosis and adversely affects patients’ quality of life (QOL). Therapeutic angiogenesis may improve mobility, mortality, and QOL in CLI patients. However, the effectiveness of gene therapy on such patients’ QOL is unknown. DVC1-0101, a non-transmissible reco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Matsumoto, Takuya, Tanaka, Michiko, Yoshiya, Keiji, Yoshiga, Ryosuke, Matsubara, Yutaka, Horiuchi-Yoshida, Kumi, Yonemitsu, Yoshikazu, Maehara, Yoshihiko
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945920/
https://ncbi.nlm.nih.gov/pubmed/27418463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep30035
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares